XML 83 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and License Agreements (Schedule of Intangible Assets Acquired) (Details) (USD $)
In Millions, unless otherwise specified
0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended
Aug. 14, 2014
Customer relationships
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
In-process research and development
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Completed Technology
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Completed Technology
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Trademarks
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Trademarks
Aug. 14, 2014
Questcor Pharmaceuticals, Inc.
Customer relationships
Mar. 19, 2014
Cadence Pharmaceuticals, Inc.
Mar. 19, 2014
Cadence Pharmaceuticals, Inc.
Completed Technology
Oct. 01, 2012
Specialty Pharmaceuticals
CNS Therapeutics, Inc.
Oct. 01, 2012
Specialty Pharmaceuticals
CNS Therapeutics, Inc.
In-process research and development
Oct. 01, 2012
Specialty Pharmaceuticals
CNS Therapeutics, Inc.
Completed Technology
Oct. 01, 2012
Specialty Pharmaceuticals
CNS Therapeutics, Inc.
Trademarks
Intangible Assets Acquired as Part of Business Combination [Line Items]                            
Amortizable intangible assets acquired         $ 5,343.3   $ 5.2 $ 34.3   $ 1,300.0     $ 73.1 $ 0.2
Indefinite lived intangible assets acquired     218.3                 18.6    
Intangible assets   $ 5,601.1             $ 1,300.0   $ 91.9      
Intangible assets acquired, weighted-average useful life 12 years     18 years   13 years       8 years     13 years 3 years